In recent years, investors have increasingly turned to factor investing as a way to diversify their portfolios and potentially achieve higher returns. Factors are specific characteristics of stocks ...

The role of circulating kidney injury molecule-1 (KIM-1) in metastatic renal cell carcinoma (mRCC): A biomarker analysis of Tide-A, a phase 2 study of first-line avelumab (ave) plus intermittent ...

The results here are bleak as well with only 4 of the rolling returns at one point outperforming the actual portfolio. Looking at the June 2023 total return, each 3-factor combination saw the bottom ...